New Tacrine Dimers Alleviate the Intracellular Amyloid-β-induced Cognitive Disturbance and Oxidative Stress in Mice

New Tacrine Dimers Alleviate the Intracellular Amyloid-β-induced Cognitive Disturbance and Oxidative Stress in Mice

Abstract This study aimed to investigate <italic>in vivo</italic> and <italic>ex-vivo</italic> the effects of tacrine dimers (TD1, TD2, TD3 and TD4) in mice with Alzheimer’s disease (AD) induced by amyloid peptide (A<italic>β</italic>42) and, respectively, evaluat...

Full description

Saved in:

Bibliographic Details
Main Authors:	ANA ELISA GONÇALVES, OTTO SPIGARIOL, LUÍSA M. DA SILVA, YURI F. REGO, CLARA HERRERA-AROZAMENA, MARÍA ISABEL RODRÍGUEZ-FRANCO, ÂNGELO DE FÁTIMA, THIAGO HENRIQUE DORING, LUCAS AUGUSTO ARAUJO, MARIA LÍGIA R. MACEDO, SUMBAL SABA, JAMAL RAFIQUE, ALDO S. DE OLIVEIRA, MÁRCIA MARIA DE SOUZA
Format:	Article
Language:	English
Published:	Academia Brasileira de Ciências 2025-07-01
Series:	Anais da Academia Brasileira de Ciências
Subjects:	Tacrine Dimers Amyloid-β (Aβ42) Cognitive Disturbance Oxidative Stress Neuroprotection
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0001-37652025001100601&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design, synthesis and biological evaluation of novel N-phosphorylated and O-phosphorylated tacrine derivatives as potential drugs against Alzheimer’s disease
by: Maja Przybyłowska, et al.
Published: (2022-12-01)

The Effect of Tacrine on Functional Response of the Lower Oesophageal Sphincter Assessed by Endoscopic Luminal Impedance Planimetry in Experimental Pigs
by: Jan Bures, et al.
Published: (2024-11-01)

The novel role of Kallistatin in linking metabolic syndromes and cognitive memory deterioration by inducing amyloid-β plaques accumulation and tau protein hyperphosphorylation
by: Weiwei Qi, et al.
Published: (2025-08-01)

The Aβ42:Aβ40 ratio modulates aggregation in beta-amyloid oligomers and drives metabolic changes and cellular dysfunction
by: Annika Haessler, et al.
Published: (2024-12-01)

Plasma phosphorylated tau 217 and amyloid‑β 42/40 for amyloid risk in subgroups
by: Heekyoung Kang, et al.
Published: (2025-08-01)

Antioxidant, anti-acetylcholinesterase, and anti-amyloid-β peptide aggregations of hispolon and its analogs in vitro and improved learning and memory functions in scopolamine-induced ICR mice
by: Chang-Hang Yang, et al.
Published: (2024-12-01)

Revealing the regulation of water dipole potential to aggregation of amyloid‐β 42 at chiral interface by surface‐enhanced infrared absorption spectroscopy
by: Manyu Zhu, et al.
Published: (2024-10-01)

An eye’s look unmasks the mystery: correlation between serum amyloid beta peptide, hippocampal volume and retinal thickness in Alzheimer`s disease
by: Ali Ahmed Abou Elmaaty, et al.
Published: (2024-11-01)

Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
by: Sei-Kyoung Park, et al.
Published: (2016-01-01)

Nasal Aβ42 mirrors brain amyloid dynamics and cognitive decline across the Alzheimer’s disease continuum
by: Da Hae Jung, et al.
Published: (2025-08-01)

Different amyloid β42 preparations induce different cell death pathways in the model of SH-SY5Y neuroblastoma cells
by: Alp Yigit Özdemir, et al.
Published: (2024-11-01)

A microbead-enhanced electrochemical platform for β-amyloid peptide (1–42) detection
by: Claudia do Amaral Razzino, et al.
Published: (2024-12-01)

Plasma biomarkers for early detection of alzheimer’s disease: a cross-sectional study in a Japanese cohort
by: Masahito Kubota, et al.
Published: (2025-06-01)

Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease
by: Chenyu Zhuang, et al.
Published: (2025-03-01)

Aβ42 induces stress granule formation via PACT/PKR pathway
by: Vijay Sankar Ramasamy, et al.
Published: (2025-02-01)

Modeling biomarker kinetics of Aβ levels in serum following blast
by: Carly Norris, et al.
Published: (2025-04-01)

Neuroprotective potential of quercetin in Alzheimer’s disease: targeting oxidative stress, mitochondrial dysfunction, and amyloid-β aggregation
by: Mohd Adnan, et al.
Published: (2025-06-01)

CSF Amyloid-β42 associates with neuropsychiatric and cognitive outcomes via cerebral glucose metabolism
by: Ali Azargoonjahromi, et al.
Published: (2025-07-01)

Exploring the Neuroprotective Effects of Grape Seed Procyanidins on Amyloid-β-Induced Toxicity in <i>Caenorhabditis elegans</i>
by: Susana González-Manzano, et al.
Published: (2024-11-01)

Lipofuscin autofluorescence confounds intracellular amyloid β detection in the aged mouse brain
by: Godfried Dougnon, et al.
Published: (2025-01-01)

Reevaluating the role of amyloid β-peptides in Alzheimer’s disease: from pathogenic agents to protective chelation mechanisms
by: Franco Cavaleri
Published: (2025-03-01)

Concentration and the value of D-dimer in the diagnosis of deep vein thrombosis
by: Van Nguyen-Thanh Phan, et al.
Published: (2023-05-01)

Cyclic Voltammetry of Human Dimeric Cystathionine
by: Sebastián Carballal, Fernando Zinola, Ruma Banerjee and Beatriz Alvarez
Published: (2008-01-01)

Prolonged Elevation of D-dimer Levels In The Post- Covid-19 Period
by: Gulay Aydin, et al.
Published: (2023-06-01)

Avenanthramide-C as Alzheimer’s Disease-Modifying Therapy: Early and Sustained Intervention Prevents Disease Progression in Mouse Models
by: Alen Benhur Pravin Nathan, et al.
Published: (2025-06-01)

Early BMI Change, Cognitive Decline, and CSF AD Biomarkers Alterations in Parkinson's Disease
by: Rui Zhong, et al.
Published: (2025-05-01)

Modern biomarkers as key tools in the early diagnosis and monitoring of Alzheimer's disease progression
by: Konrad Strużek, et al.
Published: (2025-04-01)

Effect of Circadian Rhythm Following a Period of Continuous Physical Activity in the Morning and Evening on Neuronal Degradation Factors and Mir-132 in the Hippocampus of Mice with Metabolic Syndrome
by: Asieh Sadat Mousavian, et al.
Published: (2025-06-01)

Clearing Amyloid-Beta by Astrocytes: The Role of Rho GTPases Signaling Pathways as Potential Therapeutic Targets
by: Gyeongah Park, et al.
Published: (2024-12-01)

Effect of Phytohormones of Kinetin and Epibrassinolide on Content and Intracellular Localization of Glucosides and Free Amino Acids in Pea Plants Cells (Pisum sativum L.)
by: Antonina N. Ershova, et al.
Published: (2018-07-01)

Alcohol consumption and cerebrospinal fluid biomarkers for preclinical alzheimer’s disease in a population-based sample of 70-year-olds
by: Silke Kern, et al.
Published: (2025-07-01)

Sesamol Inhibits Aβ1-42-Induced Ferroptosis by Regulating the SLC7A11/GPX4/ACSL4 Axis in PC12 Cells
by: ZHAO Peijun, WANG Tianlin, XIE Shanshan, SONG Lianjun, HUANG Xianqing, LI Tiange
Published: (2025-05-01)

The Role of Selected Flavonoids in Modulating Neuroinflammation in Alzheimer’s Disease: Mechanisms and Therapeutic Potential
by: Joanna Kruszka, et al.
Published: (2025-05-01)

Molecular recognition requires dimerization of a VHH antibody
by: Christopher A. Smith, et al.
Published: (2023-12-01)

Neon dimers in momentum and configuration spaces
by: R. Ahnouch, et al.
Published: (2025-04-01)

Administration of Polyphenol-Rich Sugarcane Extract Alleviates Deficits Induced by Amyloid-Beta<sub>1–42</sub> (Aβ<sub>1–42</sub>) in Transgenic <i>C. elegans</i>
by: Deniz Heydarian, et al.
Published: (2025-04-01)

Effect of Xenon on the Phosphorylation of Glycogen Synthase Kinase 3β and Antioxidant Enzymes in Rat Brain
by: A. N. Kuzovlev, et al.
Published: (2021-01-01)

Green Plasticizers from Dimer Acids with Selected Esters Classified Through the Nile Red [E(NR)] Polarity Scale
by: Franco Cataldo
Published: (2025-03-01)

D-dimer – laboratory aspects and clinical application
by: I. Paskaleva, et al.
Published: (2025-05-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)